Abstract
Objective To assess the COVID-19 incidence per economic activity during the Autumn wave 2020 in Belgium.
Methods The 14-day incidence of confirmed COVID–19 cases per NACE–BEL code is described in the periods immediately preceding the Belgian more strict measures of October 19, 2020, and is evaluated longitudinally by a Gaussian–Gaussian modelling two–stage approach. Additionally, the number of high-risk contacts in working segments and regions is described.
Results The peak of COVID–19 14–day incidence in most NACE–BEL sectors is reached in the period October 20-November 2, 2020 and was considerably higher than average in human health activities, residential care activities, fitness facilities, human resource provision, hairdressing and other beauty treatment and some public service activities. Human health activities, residential care activities, food and beverage service activities, hotels, arts, food retail activities, and human resources provision have high pre-lockdown incidences. The frequency of index cases that report more than two high risk contacts is increasing over time in all sectors.
Conclusion Despite the restrictive protocols present in many sectors before the Autumn wave, employees in activities where close contact with others is high, show increased risk of COVID–19 infection. Especially sports activities are among the highest risk activities. Finally, the increasing amount of high-risk contacts by COVID–19 confirmed cases is compatible with the decreasing motivation over time to adhere to the measures.
What is already known about this subject?Certain occupational sectors, such as human health and care, food and beverage, cultural and sport activities, have been related to a high risk of SARS-CoV-2 infection at the workplace.
What are the new findings?COVID-19 confirmed cases of employees are linked with the main economic activity of their employer. The effect of opening of sectors, potentially under restrictive protocols, is evaluated. Despite the restrictive protocols present in many sectors, employees in activities where close and/or prolonged contact with others is high exhibit increased risk of COVID–19 infection, even higher than the high-risk sector of human health and care. Full restriction of these sectors decreases adequately the COVID-19 incidences, even in those sectors with physical contacts that remain open, for example human health, care and food shops. Finally, the increasing amount of high-risk contacts by COVID–19 confirmed cases might be related to decreasing motivation over time to adhere to the measures.
How might this impact on policy or clinical practice in the foreseeable future?These insights offer guidance to policy makers on which economic activity to restrict or subject to stricter protocols to better control the COVID-19 pandemic whilst keeping the work floor as safe as possible.
Competing Interest Statement
1) GM acts as advisor and member of International Data Monitoring Committees for several biopharmaceutical clinical trials, including for a COVID-19 vaccination trial of JandJ; he receives research funding from GSK; (2)none of the other authors has anything to disclose.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted in accordance with Belgian and international legislation guidelines on personal data handling to guarantee privacy. In this context, the approval of the local ethics committee OG 117 for data collection during occupational health surveillance was obtained. Informed consent During medical examination, every worker is informed about the retrospective analysis of anonymised data gathered during the examination with the possibility of opting out.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Cross-sectional data are included in the article or uploaded as supplementary information. Longitudinal data are available upon reasonable request.
